Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms.

Journal of psychiatry & neuroscience : JPN - 22 Jul 2021

Tene Oren, Hallevi Hen, Molad Jeremy, Usher Saly, Seyman Estelle, Bornstein Natan M, Shenhar-Tsarfaty Shani, Ben Assayag Einor

Abstract excerpt

Background: A naturally occurring loss-of-function mutation in the gene for C-C chemokine receptor type 5 (CCR5-Δ32) has recently been reported as a protective factor in post-stroke motor and cognitive recovery. We sought to examine whether this mutation also prevented the development of depressive symptoms up to 2 years after a stroke. Methods: Participants were survivors of a first-ever mild to moderate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Polymorphism, Genetic

Share to Protective Factors

Share to Receptors, CCR5

Share to Stroke

Source

Open in PubMed Open full text

Identifiers

PMID: 34291627
DOI: 10.1503/jpn.200197
PMCID: PMC8519488

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms.PMID 34291627Read ↗

CCR5-Δ32 polymorphism-a possible protective factor from gait impairment amongst post-stroke patients.Semantic proximity Read ↗

Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.Semantic proximity Read ↗

CCR5Δ32 - A piece of protection in the inflammatory puzzle of multiple sclerosis susceptibility.Semantic proximity Read ↗

Lack of Association Between the CCR5-delta32 Polymorphism and Neurodegenerative Disorders.Semantic proximity Read ↗

Dual effect of C-C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?Semantic proximity Read ↗

Meta-Analysis on the Association between Brain-Derived Neurotrophic Factor Polymorphism rs6265 and Ischemic Stroke, Poststroke Depression.Semantic proximity Read ↗

Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.Semantic proximity Read ↗

CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia.Semantic proximity Read ↗

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.Semantic proximity Read ↗

The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.Semantic proximity Read ↗

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.Semantic proximity Read ↗

Association of CCR5 delta32 deletion with early death in multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.